Increased malignancy risk in patients with lymphangioleiomyomatosis: findings from a Chinese cohort
Increased malignancy risk in patients with lymphangioleiomyomatosis: findings from a Chinese cohort
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Lymphangioleiomyomatosis (LAM) is a rare, low-grade neoplasm. Abnormal activation of the mammalian target of rapamycin (mTOR) pathway plays a critical role in LAM pathogenesis by promoting cell proliferation, which may increase susceptibility to malignancies in these patients. However, owing to the rarity of LAM, comprehensive data on the risk of m...
Alternative Titles
Full title
Increased malignancy risk in patients with lymphangioleiomyomatosis: findings from a Chinese cohort
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_13c43005065c4f5b986ebaa969934f5f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_13c43005065c4f5b986ebaa969934f5f
Other Identifiers
ISSN
1750-1172
E-ISSN
1750-1172
DOI
10.1186/s13023-025-03834-w
